{"pageContent": "Background: Of the estimated 317,000 men in the United States diagnosed with prostate carcinoma in 1996, 57% will have localized disease, and their 5-year relative survival rate will be 98%. Limited information exists on patient-reported quality of life (QOL) and the incidence and severity of treatment-related side effects. The purpose of this study was to identify and compare patients' self-reported QOL and treatment side effects 1-5 years after radical prostatectomy or radiotherapy.", "metaData": {"source": "Sexuality and health-related quality of life after prostate cancer in African-American and white men treated for localized disease\nhttps://pubmed.ncbi.nlm.nih.gov/14742098/"}}